Objective:
The objective of this study was to assess the attitude and hesitancy towards vaccine against COVID-19 in a Pakistani Population.
Materials and Methods:
A mix-method, prospective study was conducted and adults (aged ≥18 years) residing in Pakistan were invited to participate..The questionnaire was prepared, hosted in Google Forms and circulated through electronic platforms and was also available to be done in in-person. Data was compiled from 15
th
September to 30
th
November 2020.
Results:
The response rate was 80%. A total of 1003 participants were included in the final analysis. Of them, 75% completed survey questionnaire online, while remaining 25% responded in-person. The mean age of the participants was 29.62±10.47 years. The majority of participants were females; 60.9% (n=611). 57.02% (n=572) of the participants were employed at the time of survey. Overall, 70.68% (n=709) of the participants had previous experience of vaccines such as the flu vaccine Only 4.9% (n=49) participants thought that they will be seriously ill from COVID-19 within six months and 39% (n=392) participants were confident that they will get COVID-19. A total of 71.29% of the participants reported they would consider getting vaccinated once available. There was statistical association between gender and getting vaccinated (P<0.001).
Conclusion:
This study demonstrated that majority of the participants showed positive attitude towards considering COVID-19 vaccine. However awareness with informed knowledge of efficacy, possible adverse effects and cost would be of added great value to increase the real response of Pakistani population towards COVID-19 vaccination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.